UCHealth University of Colorado Hospital or University Hospital is part of UCHealth and is a Level I trauma center and the principal teaching hospital for the University of Colorado School of Medicine, located in Aurora, Colorado.

There are 678 beds in University of Colorado Denver.

During the past decade, University of Colorado Denver conducted 322 clinical trials. In the 10-year time frame, 322 clinical trials started and 175 clinical trials were completed, i.e. on average, 54.3% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 89 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Colorado Denver" #1 sponsor was "University of Colorado, Denver" with 160 trials, followed by "National Cancer Institute (NCI)" with 33 trials sponsored, "Gilead Sciences" with 12 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials sponsored and "Fred Hutchinson Cancer Center" with 10 trials sponsored. Other sponsors include 398 different institutions and companies that sponsored additional 263 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Denver" #1 collaborator was "University of Colorado, Denver" with 48 trials as a collaborator, "National Cancer Institute (NCI)" with 25 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 22 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 20 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 18 trials as a collaborator. Other collaborators include 638 different institutions and companies that were collaborators in the rest 352 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado Denver" are "Pulmonary Arterial Hypertension" (15 trials), "Obesity" (13 trials), "Contraception" (12 trials), "Multiple Sclerosis" (10 trials) and "Parkinson Disease" (10 trials). Many other conditions were trialed in "University of Colorado Denver" in a lesser frequency.

Most popular intervention types in "University of Colorado Denver" are "Drug" (347 trials), "Other" (123 trials), "Device" (63 trials), "Behavioral" (62 trials) and "Biological" (57 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (87 trials), "Laboratory Biomarker Analysis" (17 trials), "laboratory biomarker analysis" (11 trials), "Bevacizumab" (10 trials) and "Quality-of-Life Assessment" (8 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Denver" are 556 trials for "All" genders, 59 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 173 active trials in "University of Colorado Denver". 2 are not yet recruiting, 92 are recruiting, 73 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 365 completed trials in University of Colorado Denver, 4 suspended trials, and 57 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Denver, 79 "Phase 1" clinical trials were conducted, 185 "Phase 2" clinical trials and 118 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 36 trials, and there were also 144 trials that are defined as “Not Applicable".